NAPP Logo

Respiratory

Respiratory

We are a committed long-term NHS provider in respiratory medicine, supporting the delivery of real-world evidence and education. We aim to provide high-quality asthma medicines that meet genuine needs, make a positive difference to patients’ lives and offer value to the NHS.

 flutiform® k-haler® pressurised inhalation, suspension inhaler (fluticasone propionate and formoterol fumarate dihydrate) 

For further information please visit the Patient Information leaflet or visit https://www.flutiformkhaler.co.uk/uk/home/# 

SPC PIL

flutiform® inhaler (fluticasone propionate and formoterol fumarate dihydrate) 

SPC PIL

Phyllocontin® Continus® and Phyllocontin® Forte Continus® tablets (twice-daily aminophylline hydrate)

SPC PIL

Uniphyllin® Continus® tablets (twice-daily theophylline)

SPC PIL
Back to all products

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUK@napp.co.uk.

Links and resources

The following website offers information and resources for people with asthma:

Asthma UK

British Lung Foundation

Please note that these websites are owned and managed by patient organisations/charities. Napp is not responsible for any of the content within these websites.

Date of preparation: February 2019 UK/CORP-18046a

Stay connected

You are now leaving s://napp.co.uk. Napp does not accept any responsibility for the third party site.

Please click "Continue to external link" if you want to proceed.

Back to s://napp.co.uk
Continue to external link